Biotech/GM Crops Surge to a New Peak of 185.1 Million Hectares in 2016

Global area rebounds from 2015 as farmers continue to adopt biotech crops 

The International Service for the Acquisition of Agri-biotech Applications (ISAAA) has released the Global Status of Commercialized Biotech/GM Crops: 2016, its annual report showcasing the 110-fold increase in the global adoption rate of biotech crops in 21 years of commercialization – growing from 1.7 million hectares in 1996 to 185.1 million hectares in 2016. The 2016 Report continues to demonstrate the long-standing benefits of biotech crops for farmers in developing and industrialized countries, as well as consumer benefits of recently approved and commercialized varieties. 

“Biotech crops have become a vital agricultural resource for farmers around the world because of the immense benefits for improved productivity and profitability, as well as conservation efforts,” said Dr. Paul S. Teng, ISAAA Board Chair. “With the commercial approvals and plantings of new varieties of biotech potatoes and apples, consumers will begin to enjoy direct benefits of biotechnology with produce that is not likely to spoil or be damaged, which in turn has the potential to substantially reduce food waste and consumer grocery costs.”

The adoption of biotech crops has reduced CO2 emissions equal to removing ~12 million cars from the road annually in recent years; conserved biodiversity by removing 19.4 million hectares of land from agriculture in 2015; and decreased the environmental impact with a 19% reduction in herbicide and insecticide use (Brookes and Barfoot, 2017, Forthcoming). Additionally, in developing countries, planting biotech crops has helped alleviate hunger by increasing the incomes for 18 million small farmers and their families, bringing improved financial stability to more than 65 million people. 

“Biotechnology is one of the tools necessary in helping farmers grow more food on less land. However, the promises of biotech crops can only be unlocked if farmers are able to buy and plant these crops, following a scientific approach to regulatory reviews and approvals.”

- Dr. Randy A. Hautea, ISAAA Global Coordinator

As more varieties of biotech crops are approved and commercialized for use by farmers, ISAAA expects to see adoption rates continue to climb and to benefit farmers in developing countries. For example, among African nations where regulatory processes have traditionally created barriers to biotech crop adoption rates, advances are being realized. In 2016, South Africa and Sudan increased the planting of biotech maize, soybean and cotton to 2.66 million hectares from 2.29 million hectares in 2015. Elsewhere on the continent, a new wave of acceptance is emerging as Kenya, Malawi, Nigeria, Ethiopia, Ghana, Nigeria, Swaziland and Uganda make advances in regulatory review and commercial approvals for a variety of biotech crops.

“Even with a long history of regulatory barriers, African farmers continue to adopt biotech crops because of the value they are realizing from the stability and productivity of biotech varieties,” said Hautea. “As more countries move forward with regulatory reviews for crops such as bananas, cowpeas and sorghum, we believe biotech crop plantings will continue to grow in Africa and elsewhere.”

Also in 2016, Brazil increased biotech area of maize, soybean, cotton and canola by a remarkable 11% – maintaining its ranking as the second largest producer of biotech crops after the United States. In Brazil, biotech soybeans account for 32.7 million hectares of the 91.4 million hectares grown worldwide.



For 2016, ISAAA also reports that there were improvements in the commercialization and plantings of biotech fruits and vegetables with direct consumer benefits. These included the commercial approvals of the Innate™ Russet Burbank Gen 2 potatoes that were approved by the U.S. Food and Drug Administration for sale in the United States and the Simplot Gen 1 White Russet™ brand potatoes that were approved by Health Canada for fresh market sale in Canada. These biotech potato varieties have lower levels of asparagine, which reduces the creation of acrylamide during high-heat cooking. Additionally, the first commercially saleable quantities of Arctic® Apples were harvested in 2016, stored over the winter and are projected to be sold in U.S. grocery stores in 2017.

Additional highlights from ISAAA’s 2016 report include:

• Global area rebounded in 2016 with 185.1 million hectares of biotech crops versus 179. 7 million hectares 2015, when global area for all crops was down, and 181.5 million hectares in 2014. 
• In 2016, 26 countries in total, including 19 developing and 7 industrial countries, grew biotech crops. Developing countries grew 54% of biotech crops, compared to 46% for industrial nations. 
• Eight countries in Asia and the Pacific, including China and India, grew 18.6 million hectare of biotech crops in 2016.
• 10 countries in Latin America, including Paraguay and Uruguay, grew a combined 80 million hectares of biotech crops in 2016. 
• In 2016, the leading countries growing biotech crops continued to be represented by the United States, Brazil, Argentina, Canada and India. Combined, these five countries planted 91% of the global biotech crop area. 
• Four countries in Europe -- Spain, Portugal, Czech Republic Slovakia -- grew more than 136,000 hectares of biotech maize in 2016, an increase of 17% from 2015, reflecting EU’s need for insect resistant maize. 
• Biotech crops with stacked traits accounted for 41% of global area, second only to herbicide tolerance at 47%.
• Biotech soybean varieties accounted for 50% of global biotech crop area. Based on global area for individual crops, 78% of soybean, 64% of cotton, 26% of maize and 24% of canola planted in the world were biotech varieties.
• Countries with over 90% adoption of biotech soybean are U.S.A, Brazil, Argentina, Canada, South Africa, and Uruguay; close to or over 90% adoption of biotech maize are USA, Brazil, Argentina, Canada, South Africa, and Uruguay; over 90% of biotech cotton are USA, Argentina, India, China, Pakistan, South Africa, Mexico, Australia, and Myanmar; and with 90% or more of biotech canola are USA and Canada.

For more information and other details about the report, visit the Brief 52 page at the ISAAA website.

Global Status of Commercialized Biotech/GM Crops 2013 Seminars in Indonesia, Bangladesh, and Philippines

A month after the international launch of ISAAA's 2013 Global Status of Commercialized Biotech/GM Crops in Beijing, 10 countries in Asia have held their respective launches and media seminars. ISAAA's monitoring of the tri-media shows that one month after the international launch, Brief 46 has been mentioned in 1,933 news articles and 1,777 social media posts in 77 countries with a total impression data of 2,147,275,067.

Our previous blog posts discussed the country launches in China, South Korea, Japan, Vietnam, Thailand, and Myanmar. The following are summaries of the events in Indonesia, Bangladesh, and the Philippines.


BANGLADESH

In Bangladesh, the seminar/launch for ISAAA Brief 46 was held in Dhaka, Bangladesh on February 26. The event was highlighted by the keynote speech of Agriculture Minister Matia Chowdhury. Minister Chowdhury said that "Being an overpopulated country, we will not hesitate in using biotechnology if it is proven to be useful and safe for human, animal and for the environment." She urged scientists to develop new crop varieties through frontier research using biotechnology to combat the environmental hazards like salinity, drought, submergence, and cold.

Bangladesh Biotechnology Information Centre (BdBIC) and ISAAA, in collaboration with the Bangladesh Agricultural Research Council (BARC) and Bangladesh Agricultural Research Institute (BARI) organized the seminar which was attended by around 350 policy planners, academicians, researchers, extension officers, research students, and journalists.

Dr. James (third from left) is joined by Minister Chowdhury during the launch of Brief 46 in Dhaka.

INDONESIA

The Jakarta, Indonesia seminar was held on February 28, and was attended by 128 people. Dr. Mahaletchumy Arujanan of Malaysia BIC joined Dr. Clive James and Dr. Randy Hautea by giving a presentation "Communicating Agri-biotech: Scientific Accuracy vs Popularized Myths." Two interviews for release on television were conducted featuring Dr. Clive James.

Drs. James and Hautea was joined by Dr. Arujanan during the launch in Jakarta.

PHILIPPINES

A media conference was held on March 6, 2014 at Dusit Thani Hotel, Makati City, with more than 60 people in attendance, composed of multi-media journalists, members of the academe, government agencies, private sector, non-government organizations, and local government units. At the conference, ISAAA Chair Dr. Paul Teng talked about food security and how biotech crops help contribute in various aspects of food security, such as improvement of nutrition and agricultural productivity. ISAAA Global Coordinator and SEAsiaCenter Director Dr. Randy Hautea presented the global status, trends, and significant benefits of biotech crop adoption.

Resource persons of the media conference in Makati are (Left to right): DA Undersecretary Segfredo Serrano, ISAAA Global Coordinator and SEAsia Center Director Dr. Hautea, ISAAA Chair Dr. Teng, SEARCA Director Dr. Gil Saguiguit, and Former University of the Philippines President and UPLB Chancellor Dr. Emil Q. Javier.

More information about ISAAA's Global Status of Commercialized Biotech/GM Crops: 2013 are available at ISAAA's website at http://www.isaaa.org/resources/publications/briefs/46/default.asp. Various information resources, including the Executive Summary, Top Ten Facts about Biotech/GM Crops in 2013, Powerpoint Slides, Infographics, and videos are all available for download from the same link.

For more information about ISAAA, visit http://www.isaaa.org/, or follow ISAAA on Facebook (https://www.facebook.com/isaaa.org) and Twitter (https://twitter.com/isaaa_org).

Top Ten Facts about Biotech/GM Crops in 2012

A new overview of biotech crops in 2012

Fact 1.
2012 was the 17th year of successful commercialization of biotech crops.

Biotech crops were first commercialized in 1996, and planting increased every single year between 1996 to 2012 with 12 years of double digit growth rates, reflecting the confidence and trust of millions of risk-averse farmers from both developing and industrial countries around the world.

Fact 2.
Biotech crop hectares increased by unprecedented 100-fold from 1.7 million hectares in 1996 to over 170 million hectares in 2012.

This makes biotech crops the fastest adopted crop technology in recent times. The reason – they deliver benefits. In 2012, hectarage of biotech crops grew at an annual growth rate of 6%, up 10.3 million from 160 million hectares in 2011. Millions of farmers in almost 30 countries worldwide have made more than 100 million independent decisions to plant an accumulated hectarage of almost 1.5 billion hectares, equivalent to 50% more than the total land mass of the United States or China. This growth reflects the fact that biotech crops deliver sustainable and substantial socioeconomic and environmental benefits.

Fact 3.
For the first time in 2012, developing countries planted more biotech crops than industrial countries.

Notably, developing countries grew more, 52%, of global biotech crops in 2012 than industrial countries at 48%. In 2012, growth rate for biotech crops was at least three times as fast, and five times as large in developing countries, at 11% or 8.7 million hectares, versus 3% or 1.6 million hectares in industrial countries.

Fact 4.
Number of countries growing biotech crops.

Of the 28 countries which planted biotech crops in 2012, 20 were developing and 8 were industrial countries; two new countries, Sudan (Bt cotton) and Cuba (Bt maize) planted biotech crops for the first time in 2012. Germany and Sweden could not plant the biotech potato "Amflora" because it ceased to be marketed. Stacked traits are an important feature – 13 countries planted biotech crops with two or more traits in 2012, and notably, 10 of the 13 were developing countries – 43.7 million hectares, or more than a quarter, of the 170 million hectares were stacked in 2012.

Fact 5.
Number of farmers growing biotech crops.

In 2012, a record 17.3 million farmers, up 0.6 million from 2011, grew biotech crops – remarkably over 90%, or over 15 million, were small resource-poor farmers in developing countries. Farmers are the masters of risk-aversion and in 2012, a record 7.2 million small farmers in China and another 7.2 million in India, elected to plant almost 15 million hectares of Bt cotton, because of the significant benefits it offers. In 2012 over one-third of a million small farmers in the Philippines benefited from biotech maize.

Bt cotton farmer in India.

Workers in cotton processing facility in China.

Biotech corn harvest in northern Philippines.

Fact 6.
The top 5 countries planting biotech crops.

The US continued to be the lead country with 69.5 million hectares, with an average ~ 90% adoption across all crops. Brazil was ranked second, and for the fourth consecutive year, was the engine of growth globally, increasing its hectarage of biotech crops more than any other country – an impressive record increase of 6.3 million hectares, up 21% from 2011, reaching 36.6 million hectares. Argentina retained its third place with 23.9 million hectares. Canada was fourth at 11.8 million hectares with 8.4 million hectares of canola at a record 97.5% adoption. India was fifth, growing a record 10.8 million hectares of Bt cotton with an adoption rate of 93%, In 2012, each of the top 10 countries planted more than 1 million hectares providing a broad foundation for future growth.

Fact 7.
Status of biotech crops in Africa.

The continent continued to make progress with South Africa increasing its biotech area by a record 0.6 million hectares to reach 2.9 million hectares; Sudan joined South Africa, Burkina Faso and Egypt, to bring the total number of African biotech countries commercializing biotech crops to four. Five countries, Cameroon, Kenya, Malawi, Nigeria and Uganda conducted field trials of biotech crops, the penultimate step prior to approval for commercialization. The lack of appropriate, science-based and cost/time-effective regulatory systems continue to be the major constraint to adoption. Responsible, rigorous but not onerous, regulation is needed, particularly for small and poor developing countries.

Fact 8.
Status of biotech crops in EU.

Five EU countries planted a record 129,071 hectares of biotech Bt maize, up 13% from 2011. Spain led the EU with 116,307 hectares of Bt maize, up 20% from 2011 with a record 30% adoption rate in 2012.

Fact 9.
Benefits offered by biotech crops.

From 1996 to 2011, biotech crops contributed to Food Security, Sustainability and the Environment/Climate Change by: increasing crop production valued at US$98.2 billion; providing a better environment, by saving 473 million kg a.i. of pesticides; in 2011 alone reducing CO2 emissions by 23.1 billion kg, equivalent to taking 10.2 million cars off the road for one year; conserving biodiversity by saving 108.7 million hectares of land; and helped alleviate poverty for >15.0 million small farmers and their families totaling >50 million people, who are some of the poorest people in the world. Biotech crops are essential but are not a panacea and adherence to good farming practices such as rotations and resistance management, are a must for biotech crops as they are for conventional crops.

Fact 10.
Future prospects.

Cautiously optimistic with more modest annual gains likely due to the already high rates of adoption in the principal biotech crops in mature markets in both developing and industrial countries.


For more information about ISAAA, the Global Status of Commercialized Biotech/GM Crops Briefs, and other information resources, visit the ISAAA website at http://www.isaaa.org/.

Developing Countries Dominate Global Production of Biotech Crops

The world is different today than how it was 17 years ago. Seventeen years ago, there were only 5.8 billion people in the world (The World Bank). Today, the world’s population has grown to more than 7 billion (Population Reference Bureau), and is estimated to be at a staggering 8 billion by 2030, or 17 years from now. Today, the world has more to feed, clothe, and shelter. Doing this on limited and decreasing resources and inputs is an insurmountable task – a challenge that has been met with a variety of options, including biotech crop technology.

The recently released 2012 Global Status of Commercialized Biotech/GM Crops, authored by Clive James, ISAAA Board Chair, reports that an unprecedented 100-fold increase in global biotech crop plantings was recorded last year, from 1.7 million hectares in 1996 to 170.3 million hectares in 2012, making biotech crops the fastest adopted crop technology in recent history.

Seventeen years after the first biotech crop was commercialized, or almost two decades ago, developing countries, for the first time, have grown more biotech crops than industrial countries, producing 52 percent of the total global production in 2012. Of the 28 countries that planted biotech crops last year, 20 were developing, while only 8 industrial countries planted biotech crops, compared with 19 developing and 10 industrial countries in 2011.

From 1996 to 2012, millions of farmers in almost 30 countries worldwide made the decision to plant and replant biotech crops at an accumulated hectarage of more than 1.5 billion hectares. In 2012 alone, 17.3 million farmers grew biotech crops, up by 0.6 million from 2011, of which more than 90% or over 15 million are small, resource-poor farmers in developing countries.

Two new countries, both developing, planted biotech crops for the first time last year. Sudan planted Bt cotton, while Cuba grew Bt maize. Sudan is the fourth country in Africa to plant a biotech crop after South Africa, Burkina Faso, and Egypt. About 10,000 farmers were the initial beneficiaries of the technology who have an average of 1-2.5 hectares of land. In a similar development in Latin America, Cuba became the 11^th Latin American country to plant biotech crops. For the first time, Cuban farmers grew 3,000 hectares of hybrid Bt maize commercially.

Despite the enormous leap in biotech crop production of developing countries, the USA remained and continued its leadership in producing biotech crops in 2012 with 69.5 million hectares, an average adoption rate of ~90% across all biotech crops. Since 2006, the USA has planted eight biotech crops, namely: maize, soybean, cotton, canola, sugarbeet, alfalfa, papaya, and squash. 

Second to the USA, but emerging as a global leader in biotech crop production is Brazil, which produced 36.6 million hectares of biotech crops in 2012, a total of 6.3 million hectares more than its hectarage in 2011. For the fourth consecutive year, Brazil increased biotech crop plantings more than any other country in the world.

According to Clive James, the growth seen in global production of biotech crops is “contrary to the prediction of critics, who prior to the commercialization of the technology in 1996 prematurely declared that biotech crops were only for industrial countries, and would never be accepted and adopted by developing countries.” He added that risk-averse farmers put their trust and confidence in biotechnology because biotech crops deliver substantial, sustainable, socio-economic and environmental benefits. 

Biotech crops adoption from 1996 to 2011 has contributed to food security, sustainability and climate by increasing crop production valued at US$98.2 billion; providing a better environment by saving 473 million kg a.i. of pesticides; in 2011 alone, reducing CO₂ emissions by 23 billion kg, equivalent to taking 10.2 million cars off the road; conserving biodiversity by saving 108.7 million hectares of land; and helping poverty alleviation by helping more than 15 million small, resource-poor farmers and their families, totaling more than 50 million people who are some of the poorest in the world.

Farmers in India planted a record 10.8 million hectares of Bt cotton in 2012 with an adoption rate of 93%.

The near-term looks encouraging with new improved crops such as the first biotech drought tolerant maize approved for planting in the USA in 2013 and also the first planting of the stacked soybean in Brazil and neighboring countries in South America in 2013. Vitamin A enhanced Golden rice could be released in the Philippines by 2013/2014, subject to regulatory approval. Going forward, global growth of biotech crop hectares is likely to be more modest due to the already high rate of adoption in all the principal crops in mature markets in both developing and industrial countries, the author said.

For more information about ISAAA, the Global Status of Commercialized Biotech/GM Crops Briefs, and other information resources, visit the ISAAA website at http://www.isaaa.org/.

Science and Popular Media: How Cartoonists Visualize Crop Biotechnology

Cartoons and other popular art forms such as comic strips and animation can sometimes be more powerful than words in conveying messages. They go beyond just giving information. By reflecting on popular

contemporary ideas, cartoons elicit emotions that encourage interest, inquiry, and empathy. Readers are attracted to cartoons because of its subtle humor and ability to communicate several messages in a visual and simple way. ISAAA's fourth and newest monograph in its Biotech Communication Series titled "Science and Popular Media: How Cartoonists Visualize Crop Biotechnology" explores cartoons and how they are used in communicating science.

Cartoons as Popular Media

Studies have shown that the mass media is the most frequently used source of information on science and technology. Reporters and cartoonists interpret events and societal concerns which may border on perception and perceived reality. These symbolic representations contribute to the formation of public opinion. It is important therefore to understand how media “defines” biotechnology as it contributes to informal learning and decision making.

The value of cartoons lies in the fact that public perception is often defined by a visual image. For example, the visual portrayal of “scientist” is often a detached, impersonal character in white lab coat and eyeglasses or stereotyped as having powers to wreak havoc on mankind. Neither of these two stereotypes is accurate but the general images are what the public sees and ascribes to the word “scientist”. On the other hand, cartoons can be effective channels in science education. A novel tool in science communication is the combination of caricature and satire in presenting science concepts. Cartoons are able to humor and at the same time convey scientific information in a simple, understandable, and interesting manner.

Visual Media and Biotechnology

ISAAA conducted an online and manual search of articles on biotechnology from 2000 to 2009 to determine Philippine media coverage. From a list of 1,355 articles collected from three national newspapers, a sample set of 22 cartoon illustrations or editorial cartoons was evaluated in terms of message, tone, and use of framing device, characters, and visual metaphors.

While the Manila Bulletin and Philippine Star accounted for about 70% for all newspaper articles on crop
biotechnology, about 59% of cartoons were generated by at least five artists of the Philippine Daily Inquirer (PDI). The cartoons provided the visual counterpart to the text in the absence of photos. The PDI had the only female artist among the 11 cartoonists, however, she was responsible for contributing the most number of cartoons for the period. Four of the identified cartoonists were senior artists who also did the editorial cartoons of their respective newspapers or had regular individual comic strips.

Majority of cartoons in the initial years of biotech reporting were generally negative in tone, preferred the fear appeal, and used exaggeration in the absence of concrete products and unfamiliarity with the concept. They often reflected the articles they accompanied. 

 With the commercialization of a biotech crop, cartoons were more positive in perspective, highlighting the technology’s benefits.

BiotechTOONs 

In 2011, ISAAA and the SEAMEO Southeast Asian Regional Center for Graduate Study and Research in Agriculture (SEARCA)-Biotechnology Information Center organized BiotechToons, a contest for cartoonists on biotechnology, in collaboration with the Philippine International Cartoons, Comics, and Animation, (PICCA), Inc. When provided with science-based resources in media and expert formats, cartoonists were able to provide a broader perspective or more substantive overview of the technology.

1st Place, Professional Category: Norman B. Isaac

Adding Value to Cartoons

The use of cartoons in the popularization of science and technology in general and biotechnology in particular is a continuing activity. The BiotechToons exhibit is shown during events sponsored by academic institutions and research and development agencies. Biotech cartoons are used in publications, story boards, workshop presentations as well as in designs for institutional giveaways. Aside from the Philippines, other countries within the ISAAA biotech information network such as China, Kenya, and India are using different cartoon formats to help popularize crop biotechnology concepts and issues.

Biotech sQuizBox
Biotech sQuizBox is an accordion-type cartoon publication that aims to inform secondary school students about crop biotechnology. One side of the booklet contains snippets of basic information about the history, development, and benefits of biotech crops. The other side of the booklet challenges the readers to answer exciting quizzes to further understand the subject matter. The activities include DNA extraction exercise, scientist appreciation activity, puzzles, and word problem, which can be done individually or as a group in science classes.

Mandy and Fanny
Biotechnology Information Centers (BICS) are also using cartoons in their public awareness activities. India BIC developed a 60-page educational publication Mandy and Fanny: The Future of Sustainable Agriculture, a tale of two biotech crops (Mandy as corn and Fanny as cotton). The cartoon characters discuss the attributes of biotech/genetically modified (GM) crops, and how they are gaining rapid adoption, increasing income and creating an impact on millions of farmers and consumers worldwide. Inspired by the cartoon book developed by India, the BIC in East and Central Africa produced its own version entitled Adventures of Mandy and Fanny in Kenya. It narrates the story of the maize and cotton characters that take an educational tour in the country and interact with major stakeholders (government representatives, politicians and opinion leaders, journalists, farmers and consumers). During the tour, they give insights on biotechnology and its benefits and correct misconceptions.

Lele, Dodo, and Mimi
China BIC also uses cartoons in their story boards to introduce principles, applications, safety assessment, benefits and related issues on genetic modification. These story boards are used during the Biotechnology into Campus series, where students learn in a fun way through games, plays, and story telling. Three key biotech crops in China are portrayed by Dodo (cotton), Lele (corn), and Mimi (rice).

Symbols, icons, lines, and words – these are the codes and tools that cartoonists use to simplify complex messages and transform multiple concepts into condensed ideas. Within a small space, visual metaphors masked through humor, wit, satire, and exaggeration enable a community of readers to share common concerns, values, beliefs, and aspirations. Cartoons as a popular art form can contribute to greater awareness and understanding of the technology through the use of images that the public can relate to. These visual media can be a springboard into a transparent debate and discussion on a technology that has benefits just waiting to be tapped. By providing science-based information to cartoonists, particularly those in the mass media, these visual communicators can play an important role in making this possible.

More details on the above topics are included in the monograph, available to view online and download at http://www.isaaa.org/resources/publications/science_and_popular_media_how_cartoonists_visualize_crop_biotechnology/download/default.asp.

ISAAA's Biotech Communication Series and other information resources are all available for free at http://www.isaaa.org/resources/publications/default.asp.

Islamic Scholars and Scientists Present Resolutions on Modern Biotechnology

Religious scholars have a tremendous potential in helping the public towards understanding biotechnology. In most countries, religious scholars have great public trust and considered as credible sources of information during time of crisis or when emerging technologies start to have impact on everyday life. Mosques and churches often become platforms for discussion and deliberation of such issues. Religious scholars are also often consulted by the government on issues related to bioethics and halal status of biotechnology products.

However, there is limited dialogue and discussion between scientists and religious scholars which creates a knowledge and communication barrier between the two groups. For religious scholars to play an effective role in addressing public concerns and ethical issues related to modern biotechnology, consultation between scientists and religious scholars has to be an ongoing process.

A workshop was organized with a focus on agribiotechnology and Muslim scholars to begin engagement of religious scholars with modern biotechnology. With Malaysia being a predominantly Muslim country, and with Shariah law governing the life of every Muslim, this was an obvious choice. All Muslim countries are far from being self-sufficient in terms of food production. Being net importers of food and with the yearly increase in the cultivation of genetically modified (GM) crops, the halal status of foods from GM crops becomes a topical issue. A record of 15.4 million farmers in 29 countries planted GM crops on 148 million hectares of land. The four main crops are soybean, cotton, canola and corn. These four crops give rise to hundreds of products that are used in almost every food consumed daily. Therefore, there is a strong and valid need to evaluate the halal status of products that comes from GM technology. The scientists involved in agricultural biotechnology too, have to understand the concerns and needs of the Muslim community who make up more than 20 per cent of the global population.

Religious scholars and Muslim scientists from Malaysia, Indonesia, Philippines, Iran, Saudi Arabia, Egypt, and the USA converged to discuss agribiotechnology and its permissibility in Islam in Georgetown, Penang, Malaysia on December 1 and 2, 2010. High level discussion on the technicality of recombinant technology and principles of shariah took place which resulted in the adoption of a resolution that states the halal status of GM products, the need for modern biotechnology in the Muslim world and the obligation of Muslim community in harnessing this beneficial technology.

Malaysia Biotechnology Information Center (MABIC), the International Halal Integrity Alliance (IHIA), and ISAAA co-organized the international workshop with a focus on alleviating the existing food problems and poverty. The International Workshop of Islamic Scholars and Experts in Modern Biotechnolgy on “Agri-biotechnology: Shariah Compliance” agreed upon the following resolutions:

1. Islam and science are complementary and Islam supports beneficial scientific innovations for mankind. Modern biotechnology and genetic engineering are important developments that merit promotion in all OIC Members. Regulatory measures should facilitate the acceptance and use of GM products particularly by Muslims. Genetic modification and GM products are Halal as long as the sources from which they originate are Halal. The only Haram cases are limited to products derived from Haram origin retaining their original characteristics that are not substantially changed.
2. Modern biotechnology and genetic engineering are methods of plant improvement and intrinsically are not different from other plant improvement techniques from the shariah point of view.
3. In ensuring food security, our Islamic obligations require us to urge all Muslim countries, governments, international organizations and research institutions, to support research and development and use of modern biotechnology, genetic engineering and their products.
4. Because of their positive impacts on agriculture and the urgency of food security for Muslim Ummah, promotion of modern biotechnology and genetic engineering are considered “Fardhu Kifayah” (collective obligation) and should not be neglected from the shariah point of view.
5. Public awareness and education on modern biotechnology and genetic engineering, demand continuous interaction between the Islamic scholars, scientists and the general public.
6. Transparent and complete scientific information should be available for the interested stakeholders for informed decision making.

The proceedings of this international workshop is available for free download at http://www.isaaa.org/resources/publications/shariah_compliance/download/default.asp

For more information materials, visit the biotech information resources page at ISAAA's websitehere: http://www.isaaa.org/resources/default.asp.

Welcome!

Hello! Welcome to ISAAA’s blog, a new venue to learn more about our activities and publications, and read on news, features, events, and other important agbiotech developments around the world.

ISAAA’s blog is our latest foray into social media. Our Twitter (isaaa_org) and Facebook (facebook.com/isaaa.org) accounts are steadily gaining followers from all over the world, and we hope that our blog will have the same following.

Check back soon for more! Or, if you have comments, suggestions, and topics you want to see in this blog’s pages, send us a message in the comments box, or email us at knowledge.center@isaaa.org.